Introduction
============

Mouse hepatitis virus 3 (MHV3) is a natural murine viral infection that, in experimental conditions, has a resistance pattern dependent on the genetic background of the animal. BALB/c mice are susceptible and adult A/J mice are resistant to MHV3. Our previous studies have shown that resistance to MHV3 infection in mouse populations can be a consequence of a T-cell dependent mechanism, in which the production of interferon-*γ* (IFN*γ*) and the sensitivity of macrophages (M*Φ*) to IFN*γ* play an essential role ([@bib38]). We have shown that the resistance of A/J mice to an MHV3 isolate that we have cloned, selected and amplified, is acquired after immunization with ultraviolet inactivated MHV3 (uvMHV3) and that IFN*γ* activation induces an antiviral state only in M*Φ* from resistant mice, leading to a partial restriction of multiplication by significantly delaying virus replication. Recently, we have demonstrated that murine M*Φ* are capable of secreting IFN*γ* upon a synergistic stimulation with interleukin (IL)-12 and IL-18, or an autocrine and T-cell independent M*Φ* activation mechanism ([@bib23], [@bib26]).

In M*Φ*, nitric oxide synthase (NOS) and arginase are inducible enzymes that act on a common substrate, arginine. As a consequence, arginine is oxidized by NOS producing citrulline and nitric oxide (NO) or is hydrolyzed by arginases producing ornithine and urea. Ornithine is in turn catabolyzed by ornithine decarboxylase (ODC) for polyamine (putrescine, spermidine and spermine) biosynthesis or ornithine amino transferase (OAT) for glutamate or proline synthesis ([Fig. 1](#fig1){ref-type="fig"} ). Difluoromethylornithine (DFMO), an analog of ornithine that inhibits ODC, has been used in the study of polyamine depletion ([@bib39]). Polyamines, such as spermine, play several roles in cell differentiation and proliferation ([@bib36]). Despite contradictory observations, it is generally accepted that polyamines contribute to virus maturation ([@bib3]). We have recently shown that a competition between NOS and arginase for their substrate takes place in mouse bone marrow-derived M*Φ* (BMM*Φ*) and that they appear to define two alternate functional states of M*Φ*, induced by, respectively, Th1 (IFN*γ*) and Th2 cytokines (IL-4 and IL-10) ([@bib24], [@bib25]). These cytokines would also differentially regulate NOS2 and arginase 1 in vivo ([@bib12]).Fig. 1Scheme of arginine metabolism. *AL*, arginine succianate lyase; *AS*, arginine succianate synthase; NO, nitric oxide; *NOS II*, nitric oxide synthase II; *OAT*, ornithine amino transferase; *ODC*, ornithine decarboxilase; *OCT*, ornithine carbamyl transferase; OH-, Hydroxi-; DFMO, DFMO; Th1/Th2, T helper lymphocytes types 1 and 2 cytokines.

NO has been considered an important molecule with protective or harmful effects on the organism and is directly involved in antiviral activities ([@bib2]; [@bib10]; [@bib14]; [@bib28]; [@bib29]; [@bib32]; [@bib37]). Protective effects of NO have been related to infections involving ectromelia, vaccinia and herpes simplex 1 viruses ([@bib11]; [@bib19]), Coxsackie B3 virus ([@bib18]; [@bib32]), Epstein-Barr virus ([@bib13]) and Japanese encephalitis virus ([@bib33], [@bib34]). On the other hand, there are indications that NO may not be essential for virus clearance in vaccinia virus-infected mice ([@bib30]) or tick-borne encephalitis virus infection ([@bib15]). Although arginase induction in M*Φ* and its consequences has been poorly studied ([@bib5], [@bib6]; [@bib21]), some reports implicate arginase in antiviral activities in M*Φ*, tumor cell cytotoxicity and immune response ([@bib1]; [@bib20]; [@bib27]). More recent studies indicate that arginase induction is involved in host response to microbial infections although its protective or harmful role is uncertain ([@bib22]; [@bib31], [@bib40]).

Concerning MHV3 infection, we have suggested in a previous publication that the anti-MHV3 state induced by IFN*γ* in M*Φ*, which may contribute to resistance, was not related to arginine metabolism ([@bib28]). Later published data indicate that resistance to MHV3 is dependent on the production of NO ([@bib29]). Besides the fact that different mechanisms may contribute to resistance, a controversial finding seems to be a defect of NO production in susceptible BALB/c mice. Nevertheless, recent studies indicate that BALB/c mice are capable of producing NO in vivo ([@bib7]; [@bib16]). Unpublished data from our group show also that, in certain conditions, BALB/c mice are capable of producing NO in vivo, as evaluated by direct Electron Paramagnetic Resonance (EPR) spectroscopy in blood and liver. Genetic differences of the virus isolate or mouse strain used, as well as the basic mechanism considered for resistance may account for the divergent findings.

In this paper we investigate arginine metabolism associated with the autocrine pathway of IFN*γ* activation in M*Φ* of mice resistant and susceptible to MHV3.

Materials and methods
=====================

Mice, macrophages and virus
---------------------------

BALB/c and A/J mice were obtained from the mouse colonies of the Instituto Butantan, Instituto de Ciências Biomédicas of the University of São Paulo or Max-Planck Institute for Immunobiology, Freiburg, Germany. They were kept under conventional conditions and used when 4--8 weeks old. Care of animals followed the appropriate guidelines.

BMM*Φ* of mice were obtained from bone marrow cells collected from femurs by flushing of cavities with Dulbecco\'s modified MEM (DMEM) (Biochrom AG, Berlin, Germany) supplemented with 100 U/ml of penicillin (Sigma) and 100 μg/ml streptomycin (Sigma Chemical Co., St Louis, MO). As clearly described in another publication ([@bib26]) these BMM*Φ* population are homogeneously F4/80+, MAC-1+, I-A+, B7.1+, CD16/32+ with no detectable cells expressing T, B or NK cell markers (CD3, CD4, CD8, CD19, CD5, B220, DX5, NK1.1). Cells were cultured in non-toxic Teflon bags (fluorinated ethylene propylene, Biofolie 25; Heraeus GmbH, Hanau, Germany) as described ([@bib23]). The Teflon foils were folded and sealed with a diathermal sealing apparatus (Polystar 100 B and Polystar 401 M-RPA; Rische+Herfurth GmBH, Hamburg, Germany) to give rectangular bags, and subjected to gas sterilization. Cells (5×10^4^/ml) in DMEM with 10% fetal bovine serum (FBS) (Biochrom AG), 5% horse serum (Invitrogen-Gibco Co., Carlsbad, CA), 15% L929 supernatant as a source of colony-stimulating factor, 100 U/ml penicillin, 100 μg/ml streptomycin, 1% sodium pyruvate (Invitrogen-Gibco) and 0.5% 2-mercaptothanol (Sigma) were incubated for 12 days at 37 °C in the presence of 10% CO~2~. Cells were detached by repeated careful stretching of the Teflon bags, washed once with medium, transferred to 96-well microplates at a concentration of 2×10^5^  cells/100 μl and used in the experiments. Peritoneal macrophages (PM*Φ*) were prepared from peritoneal exudate cells collected by peritoneal lavage with DMEM containing 10% FBS and cultured in 96-well microplates at a concentration of 2×10^5^  cells/100μl. The cells were incubated for 2 h at 37 °C in 5% CO~2~, washed three times with DMEM after vigorous shaking to remove non adherent cells and used in the experiments. Although carefully treated, the PM*Φ* population may contain a few other cells.

MHV3, originally obtained by the Institute of Virology, University Louis Pasteur, Strasbourg from Dr. J.L. Virelizier, Institut Pasteur, Paris, was cloned by limiting dilution; one plaque was selected and amplified on L929 cells to serve as the inoculum for future stocks to limit spontaneous mutations. Samples were then transferred to the Max Planck Institute of Immunobiology, Freiburg and to the Laboratory of Virus Immunology, Institute Butantan, São Paulo. Aliquots containing 2×10^5^ plaque-forming units per milliliter (PFU/ml) were stored at −80 °C and used in all experiments. The stocks as well as experimental samples were always titrated by plaque assay on L929 cells as previously described ([@bib38]).

IFN*γ* assays
-------------

In order to study the synthesis of IFN*γ*, BALB/c or A/J mouse PM*Φ* or BMM*Φ* cultures were stimulated with 10 ng/ml of IL-12 (R&D Systems Europe Ltd., Abingdon, UK) and/or 50 ng/ml of IL-18 (PeproTech EC Ltd., London, UK) for the indicated periods. The total cellular RNA was then extracted to evaluate the expression of the IFN*γ* gene and the supernatants collected to quantify the level of IFN*γ* secreted. RNA was extracted using the TriFast reagent (PEQLAB Biotechnologie GmBH, Erlangen, Germany), which briefly includes the following steps: homogenization, phase separation, RNA precipitation, RNA wash and RNA solubilization. The final RNA concentrations and degree of purity were determined by optical spectroscopy. Only highly purified preparations (OD~260~/OD~280~=1.8--2.0) were used. Reverse transcription was performed by standard procedures using Moloney murine leukemia virus reverse transcriptase (Amersham Biosciences Europe GmbH, Freiburg, Germany) and 1 μl of a dilution of the reverse transcription mixture was used for amplification by polymerase chain reaction (PCR). The primers, the fragment obtained after 35 cycles and the annealing temperature were as follows: up, 5′-GCT CTG AGA CAA TGA ACG CT-3′; down, 5′-AAA GAG ATA ATC TGG CTC TGC-3′, 227 bp, 58 °C. The PCR products were run on a 1.5% agarose gel and stained with ethidium bromide.

IFN*γ* secreted in the supernatants was determined by the OptEIA, mouse IFN*γ* Set, a commercially available (BD Biosciences-Pharmingen, San Diego, USA) sandwich enzyme-linked immunosorbent assay (ELISA), according to the manufacturer\'s protocol. The data are expressed in pg/ml of IFN*γ* measured in triplicate cultures±standard deviation.

MHV3 replication in macrophages
-------------------------------

Experiments were carried out in order to evaluate, in the M*Φ*, the induction of anti-MHV3 state, mediated by exogenous IFN*γ* or the endogenous IFN*γ* synthesized upon IL-12/IL-18 activation. BALB/c or A/J mouse PM*Φ* or BMM*Φ* cultures were activated for 24 h with 100 U/ml of IFN*γ* (Genentech Inc., South San Francisco, CA) or 10 ng/ml of IL-12 and/or 50 ng/ml of IL-18 and then infected with MHV3 at multiplicity of infection (moi) of 0.1. Cell supernatants were collected 18 h later and the virus titers determined by plaque assay as indicated above. The data are expressed as plaque-forming units per milliliter (PFU/ml) measured in triplicate cultures±standard deviation. In order to investigate the influence of polyamine depletion by DFMO, BALB/c or A/J mouse BMM*Φ* cultures were treated for 24 h with 10 mM DFMO (EMD Biosciences Inc., Calbiochen, San Diego, CA) and then infected with 0.1 moi of MHV3 for 18 h. Supernatants were titrated and the results expressed as described above.

Measurement of NO synthesis and arginase activity in macrophages
----------------------------------------------------------------

To evaluate the induction of NO synthesis and arginase activity, BALB/c or A/J mouse BMM*Φ* cultures were activated for 24 h with 100 U/ml of IFN*γ* or 10 ng/ml of IL-12 and/or 50 ng/ml of IL-18 or with 20 U/ml of IL-4 (R&D Systems Europe) and 40 U/ml of IL-10 (PeproTech EC) and then the supernatants and the cells were collected to measure, respectively, the NO synthesis and arginase activity.

NO was measured as nitrite using the Griess reagent as previously described ([@bib21]). Briefly, culture supernatants (100 μl) were mixed with 100 μl of 1% sulfanilamide, 0.1% naphtylethylenediamine dihydrochloride (NED) and 2.5% H~3~PO~4~ and absorbance was measured at 540 nm in an ELISA reader (Biochrom AG). The data are expressed in μM measured in triplicate cultures±standard deviation.

Arginase activity was measured in cell lysates as previously described ([@bib4]). Briefly, 10^6^  cells were lysed with 0.5 ml 0.1% Triton X100 and after 30 min 0.5 ml 25 mM Tris--HCL 5 mM MnCl~2~, pH 7.4, was added. The enzyme was then activated by heating for 10 min at 56 °C. Arginine hydrolysis was carried out by incubating 25 μl of the activated lysate with 25 μl of 0.5 M arginine, pH 9.7 at 37 °C for 60 min. The reaction was stopped with 400 μl of an acidic mixture (H~2~SO~4~, H~3~PO~4~ and H~2~O, 1:3:7 v/v). The urea was then measured at 540 nm after addition of 25 μl of 9% alpha-isonitrosopropiophenone (dissolved in 100% ethanol) and then heating at 100 °C for 45 min. One unit of enzyme activity is defined as the amount of enzyme which catalyses the formation of 1 μmol of urea/min. The data are expressed as mU/10^6^ cells measured in triplicate cultures±standard deviation.

Arginine consumption and polyamine synthesis in macrophages
-----------------------------------------------------------

With the aim of investigating arginine metabolism, BALB/c or A/J mouse BMM*Φ* cultures were activated for 24 h with 20 U/ml of IL-4 or 100 U/ml of IFN*γ* (Genentech Inc.) or 10 ng/ml of IL-12 and/or 50 ng/ml of IL-18 and then infected with 0.1 moi of MHV3 for 2 h. The cultures were then washed and incubated with arginine free DMEM containing 2% FBS and 0.1 μCi of [l]{.smallcaps}-(U-^14^C) arginine (Amersham) per well. Microplates were then incubated for 4 h at 37 °C and freeze-thawed twice at −80 °C for cell lysis.

Arginine consumption and the synthesis of its products were evaluated by Thin-Layer Chromatography (TLC) ([@bib35]). To identify the spots, 10 ml of a solution containing 2.5 mg/ml of citrulline, glutamate, proline, ornithine, putrescine, spermidine and spermine was added to the cell lysates. 20 ml of the samples were spotted onto TLC plates (25-Cromatoplates TLC 20×20 cm, Silica Gel 60 F254) (Merck KGaA, Darmstadt, Germany) and dried for 1 h at 42 °C. They were then developed in the solvent system chloroform/methanol/ammonium hydroxide/water 1:9:4:2 (vol/vol) and dried. Spots were developed with Ninhydin (Spray Solution Merck) by heating at 120 °C for 5 min and scraped into scintillation tubes containing 6 ml EcoscintATM (National Diagnostics, Atlanta, GA). Radioactivity was determined by scintillation counting (Beckman Instruments Inc., Fullerton, CA) and the values for each compound are expressed as percentage (%) of the total radioactivity measured in triplicate cultures±standard deviation.

Statistical analysis
--------------------

Mean and standard deviations (bars) were calculated. The significance levels were assessed by Student\'s *t*-test at a confidence level of $p < 0.01$

Results
=======

IFN*γ* induction and MHV3 replication in BALB/c and A/J mouse macrophages upon activation with IL-12 and IL-18
--------------------------------------------------------------------------------------------------------------

Studies performed to investigate IFN*γ* induction in activated M*Φ* are shown in [Fig. 2](#fig2){ref-type="fig"} . Only upon a synergistic IL-12/IL-18 activation, BMM*Φ* from *spf* BALB/c and A/J mice were capable of synthesizing the IFN*γ* gene as shown by RT-PCR or secrete IFN*γ* into the supernatant culture as shown by specific ELISA assay. The treatment of BMM*Φ* from these *spf* mice with only IL-12 or IL-18 failed to either induce expression of the IFN*γ* gene or secretion of IFN*γ* during the first 48 h. BALB/c mouse M*Φ* were shown to regularly synthesize higher amounts of IFN*γ* (3200±60 pg/ml for BALB/c BMM*Φ* and 1600±20 pg/ml for A/J BMM*Φ* after 72 h of activation) and the studies showed that, in BMM*Φ* of both mouse strains, the IFN*γ* mRNA and secreted IFN*γ* could be detected after 24 h of IL-12/IL-18 activation. The amount of secreted IFN*γ* present in supernatants increased consistently from 24 to 72 h (from 1500±20 to 3200±60 pg/ml in BALB/c BMM*Φ* and from 500±10 to 1600±20 pg/ml in A/J BMM*Φ*). At that time (72 h) some IFN*γ* could be detected in cultures treated only with IL-18 (1200±20 pg/ml in BALB/c BMM*Φ* and 750±30 pg/ml in A/J BMM*Φ*). When PM*Φ* of non-*spf* BALB/c or A/J mice were used in the experiments, secreted IFN*γ* could be detected in high amounts upon activation with IL-12 or IL-18 alone (3100±200 or 3800±180 pg/ml for BALB/c PM*Φ* and 1500±100 or 3200±60 pg/ml for A/J PM*Φ*) in addition to the synergistic IL-12/IL-18 activation (4000±50 pg/ml for BALB/c PM*Φ* and 3600±40 pg/ml for A/J PM*Φ*).Fig. 2Induction of IFN*γ* in BALB/c and A/J mouse macrophages upon activation with IL-12 and/or IL-18. (A) Agarose gel electrophoresis of RT-PCR product specific for IFN*γ* mRNA from bone marrow macrophages (BMM*Φ*) of BALB/c or A/J *spf* mice after 24 h treatment with IL-12 and/or IL-18. (B) Kinetics of IFN*γ* synthesis in BMM*Φ* of BALB/c or A/J *spf* mice after 24--72 h treatment with IL-12 and/or IL-18. IL-12 (10 ng/ml) and IL-18 (50 ng/ml). (C) IFN*γ* synthesis in peritoneal exudate macrophages (PM*Φ*) of BALB/c or A/J *spf* or non-*spf* mice after 24 h treatment with IL-12 and/or IL-18. M, size markers; arrow, 227 kb mRNA for IFN*γ* specific DNA product. Each bar represents the mean±SD of the results from independent experiments. \*Significant ($p < 0.01$), as compared to controls.

Cultured macrophage populations activated with IL-12, IL-18 or exogenous IFN*γ* were assayed for their ability to restrict MHV3 after infection. The data shown in [Fig. 3](#fig3){ref-type="fig"} demonstrate that both BMM*Φ* and PM*Φ* from resistant A/J mice were capable of restricting MHV3 multiplication only when synergistically activated with IL-12/IL-18 (inhibition of 90.9% and 94% for PM*Φ* and BMM*Φ*, respectively) (5.5±0.5×10^5^ PFU/ml and 3±1.1×10^5^ PFU/ml for control PM*Φ* and BMM*Φ*, respectively, and 5±3.1×10^4^ PFU/ml and 3±0.8×10^4^ PFU/ml for IL-12/IL-18 activated PM*Φ* and BMM*Φ*, respectively) or with exogenous IFN*γ* (inhibition of 92.8% and 96% for PM*Φ* and BMM*Φ*, respectively) (4±0.7×10^4^ PFU/ml and 2±0.4×10^4^ PFU/ml for IFN*γ* activated PM*Φ* and BMM*Φ*, respectively). In contrast, no MHV3 multiplication restriction was observed in macrophages from the susceptible BALB/c mice (values from 5 to 7.5×10^5^  PFU/ml).Fig. 3Anti-MHV3 state induced in peritoneal (PM*Φ*) or bone marrow (BMM*Φ*) macrophages of BALB/c and A/J *spf* mice upon activation with IL-12, IL-18, IL-12+IL-18 or IFN*γ*. Macrophage cultures were activated with IL-12 (10 ng/ml), IL-18 (50 ng/ml), IL-12+IL-18 (respectively, 10 ng/ml+50 ng/ml) or IFN*γ* (100 U/ml) for 24 h and then infected with 0.1 moi of MHV3 for 18 h. Supernatants were collected and virus titers evaluated. Data are reported as PFU/ml and each bar represents the mean±SD of the results from independent experiments. C, control experiment of non-activated macrophages. \*Significant ($p < 0.01$), as compared to controls. The percentage (%) of virus inhibition is indicated in italics.

Arginine metabolism in BALB/c and A/J mouse macrophages upon activation with IL-12, IL-18, IFN*γ* and infection with MHV3
-------------------------------------------------------------------------------------------------------------------------

As shown in [Fig. 4](#fig4){ref-type="fig"} the background levels of nitrites and arginase activity found in cultured BMM*Φ* of BALB/c and A/J mice were low (\<4 μM). Nevertheless, high amounts of nitrites could be induced upon activation with IFN*γ* (70±5 and 50±5 μM for BALB/c and A/J BMM*Φ*, respectively) or by the synergistic treatment with IL-12/IL-18 (35±6 and 20±2 μM for BALB/c and A/J BMM*Φ*, respectively). In both situations higher amounts of nitrites were observed in BALB/c BMM*Φ* and no nitrite synthesis was observed upon treatment with IL-12 or IL-18 alone or with IL-4/IL-10. The MHV3 infection was capable of further enhancing the IFN*γ* or IL-12/IL-18 triggered-nitrite release from both BMM*Φ* populations (data not shown).Fig. 4Induction of NO synthesis and arginase activity in bone marrow derived macrophage cultures of BALB/c and A/J *spf* mice upon activation with IL-12, IL-18, IL-4, IL-10 or IFN*γ*. Macrophage cultures were activated for 24 h with IL-12 (10 ng/ml), IL-18 (50 ng/ml), IL-12+IL-18 (respectively, 10 ng/ml+50 ng/ml), IL-4 (20 U/ml), IL-10 (40 U/ml) or IFN*γ* (100 U/ml) and nitrite (A) or arginase (B) concentrations measured in the supernatants. Nitrites are expressed in μM and arginase in mU/10^6^ cells. Each bar represents the mean±SD of the results from independent experiments. C, control experiment of non-activated macrophages. \*Significant ($p < 0.01$), as compared to controls.

On the other hand, as also shown in [Fig. 4](#fig4){ref-type="fig"}, arginase activity was not induced in either BALB/c or A/J BMM*Φ* upon IFN*γ* activation or synergistic treatment with IL-12/IL-18 (\< 40 mU/10^6^  cells). Nevertheless high and comparable amounts of arginase activity could be induced in BMM*Φ* populations from both strains upon treatment with IL-4/IL-10 (2100±400 mU/10^6^ cells and 1800±200 mU/10^6^ cells for BALB/c and A/J BMM*Φ*, respectively). The background levels of arginase activity were higher in BALB/c BMM*Φ* than in A/J ones (15±4 mU/10^6^  cells and 5±2 mU/10^6^  cells for BALB/c and A/J BMM*Φ*, respectively) and the MHV3 infection did not influence significantly the arginase activity (data not shown).

The studies of arginine consumption and synthesis of citrulline, ornithine and spermine are shown in [Fig. 5](#fig5){ref-type="fig"} . The data show that highly enhanced arginine consumption was observed in BMM*Φ* of both BALB/c and A/J mice upon activation with exogenous IFN*γ* (17±1% or 18±2% for controls and 54±2% or 55±3% for IFN*γ*-activated in BALB/c and A/J BMM*Φ*, respectively) but not when the cells were treated with IL-12 and/or IL-18 (18±1% for BALB/c and 18±3% for A/J BMM*Φ*). In these cases, MHV3 always further enhanced the arginine consumption (30±2% or 35±2% for controls or 66±0.1% or 72±4% for IFN*γ*-activated BALB/c and A/J BMM*Φ*, respectively). Comparable values of arginine consumption were observed in BMM*Φ* of both BALB/c and A/J mice independent of the treatment.Fig. 5Consumption of arginine (A) and synthesis of citrulline (B), ornithine (C) and spermine (D) in bone marrow derived macrophages of BALB/c and A/J *spf* mice upon activation with IL-12, IL-18, IL-12+IL-18, IFN*γ* or IL-4 and infection with MHV3. Macrophage cultures were activated with IL-12 (10 ng/ml), IL-18 (50 ng/ml), IL-12+IL-18 (respectively, 10 ng/ml+50 ng/ml), IFN*γ* (100 U/ml) or IL-4 (20 U/ml) for 24 h and infected with 0.1 moi of MHV3 for 2 h. After washing and treatment for 4 h with [l]{.smallcaps}-(U-^14^C) arginine the cultures were lysed and submitted to TLC. The results of arginine consumption or citrulline, ornithine or spermine synthesis are expressed in percent (%) of total radioactivity. Each bar represents the mean±SD of the results from independent experiments. C, control experiment of non-activated nor infected macrophages. \*Significant ($p < 0.01$), as compared to controls.

Comparable basal levels of citrulline were observed in BALB/c and A/J BMM*Φ*, but upon IFN*γ* activation, it was synthesized in high amounts in BMM*Φ* of both mouse strains (31±4% and 40±2% in BALB/c and A/J BMM*Φ*, respectively) and could be further increased by MHV3 infection (48±3% and 55±4% in BALB/c and A/J BMM*Φ*, respectively). It correlated with our previous data ([Fig. 4](#fig4){ref-type="fig"}) showing that IFN*γ* was capable of inducing NO synthesis, which was also further enhanced by MHV3 infection.

Overall polyamine synthesis was found to be lower in BALB/c BMM*Φ* than in A/J ones (6.9±3% and 14±2% of spermine in control BALB/c and A/J BMM*Φ*, respectively), which correlated with the levels of ornithine observed (4±1.5% and 2±1.5% in BALB/c and A/J BMM*Φ*, respectively). MHV3 infection was capable of enhancing spermine synthesis (20±2% and 32±3% of spermine in MHV3 infected BALB/c and A/J BMM*Φ*, respectively).

IFN*γ* activation or synergistic treatment with IL-12/IL-18, mainly in MHV3 infected cells, led to a decreased synthesis of spermine only in A/J BMM*Φ* (14±2%, 8±1%, 32±3% and 12±2% in control, IFN*γ*-activated, MHV3 infected and MHV3 infected/IFN*γ*-activated A/J BMM*Φ*, respectively).

Overall putrescine and spermidine synthesis (data not shown) showed the same pattern as that of spermine ([Fig. 5](#fig5){ref-type="fig"}) but at lower levels (0.69±0.2% and 1.3±0.6% of putrescine, and 0.49±0.2% and 0.76±0.3% of spermidine in control BALB/c and A/J BMM*Φ*, respectively; 1.12±0.6% and 1.75±0.5% of putrescine, and 1.1±0.2% and 1.25±0.4% of spermidine in MHV3 infected BALB/c and A/J BMM*Φ*, respectively).

Upon stimulation with IL-4 we could observe a high consumption of arginine in both BALB/c and A/J BMM*Φ* (95±2% in both BALB/c and A/J BMM*Φ*), followed by lower synthesis of citrulline (17±1% and 13±1% in BALB/c and A/J BMM*Φ*, respectively) and higher synthesis of ornithine (38±1% and 36±2% in BALB/c and A/J BMM*Φ*, respectively) and spermine (34±1% and 44±1% in BALB/c and A/J BMM*Φ*, respectively) when compared to IFN*γ* activation ([Fig. 5](#fig5){ref-type="fig"}).

As shown in [Table 1](#tbl1){ref-type="table"} , the inhibition of ODC activity by DFMO, which leads to a depletion of polyamines, induced a decrease in the MHV3 replication in both BALB/c (7±0.4×10^6^ to 0.8±0.02×10^6^ PFU/ml in control and DFMO-treated M*Φ*, respectively) and A/J BMM*Φ* (4±0.3×10^6^ to 0.3±0.01×10^6^ PFU/ml in control and DFMO-treated M*Φ*, respectively).Table 1MHV3 replication in bone marrow derived macrophages of A/J and BALB/c mice. Macrophage cultures were treated with 10 mM DFMO for 24 h and then infected with 0.1 moi of MHV3 for 18 hTreatmentPFU/ml±SDBALB/cA/J---7.0±0.4×10^6^4.0±0.3×10^6^DFMO0.8±0.02×10^6^\*0.3±0.01×10^6^\*[^1]

Discussion
==========

MHV3, a coronavirus found endemically in mouse colonies, has been used as a model of hepatotropic virus infection. Among the mechanisms proposed for resistance of some mouse strains to experimental MHV3 infection ([@bib8]; [@bib17]), we have described a T-cell dependent one in which IFN*γ* synthesis and M*Φ* sensitivity to IFN*γ* play a central role. Susceptible mice would develop a fatal hepatitis by lacking either the ability to synthesize IFN*γ* or cells capable of responding to IFN*γ*. IFN*γ* would exert its activity by down-regulating the expression of the main viral receptor ([@bib38]). Recently, we have also shown a novel pathway of autocrine M*Φ* activation by demonstrating that M*Φ*, upon synergistic stimulation with IL-12 and IL-18, are a potent IFN*γ*-producing cell ([@bib23]). BMM*Φ* are a reliable non contaminated population which can support these findings ([@bib26]). So, along with the classical or paracrine M*Φ* activation by IFN*γ* produced by lymphoid cells, an autocrine M*Φ* activation could take place, where IFN*γ* is produced by IL-12/IL-18-activated M*Φ*. Although their relative magnitudes are not yet known, both processes occurring in M*Φ* could play a crucial role in controlling infections.

In the present work we extended our previous observations ([@bib38]) concerning M*Φ* activation by exogenous IFN*γ*, which leads to a partial restriction of MHV3 replication only in M*Φ* of resistant mice, to the participation of the autocrine M*Φ* activation in MHV3 restriction. The data presented show that synergistic activation by IL-12/IL-18 of M*Φ* from resistant (A/J) and susceptible (BALB/c) mouse strains induced the expression of the IFN*γ* gene ([Fig. 2A](#fig2){ref-type="fig"}). BMM*Φ* or PM*Φ* of both *spf* mouse strains secreted IFN*γ* upon a synergistic IL-12/IL-18 activation ([Fig. 2C](#fig2){ref-type="fig"}) and the levels of secreted IFN*γ* increased along the time of stimulation and were higher in BALB/c M*Φ* ([Figs. 2B and C](#fig2){ref-type="fig"}). Nevertheless, an anti-MHV3 state was observed only in A/J M*Φ* upon a synergistic activation with IL-12/IL-18 or with exogenous IFN*γ* ([Fig. 3](#fig3){ref-type="fig"}). As expected, in the PM*Φ* of non-*spf* animals, IFN*γ* synthesis could be observed also among M*Φ* stimulated only with IL-12 or IL-18. Taken together, these results demonstrate that autocrine M*Φ* activation takes place in both BALB/c and A/J M*Φ* and, as shown for paracrine IFN*γ* M*Φ* activation, only A/J M*Φ* respond with the expression of an anti-MHV3 state. Both BMM*Φ* and PM*Φ* behave similarly regarding IFN*γ* synthesis and anti-MHV3 state. Among non-*spf* mice, which better mirror the natural state of mice concerning this endemic virus infection, their PM*Φ* synthesize high levels of IFN*γ* upon treatment with only IL-12 or IL-18 possibly due to their already immunologically primed state or to the presence of other cells. The evidence that, after 72 h, the BMM*Φ* from *spf* mice synthesized some IFN*γ* upon stimulation of only IL-18, may rely on the autocrine pathway. The contribution of each, the paracrine, T-cell dependent, and the autocrine, T-cell independent, mechanism of M*Φ* activation during MHV3 infection remains to be determined. It is conceivable that autocrine-IFN*γ* synthesis participates in early stages of infection, prior to specific antigen recognition by lymphoid cells, not only by enhancing the M*Φ* ability to restrict the agent\'s infectivity but also by enhancing the M*Φ* ability to present antigens. By this way, autocrine M*Φ* activation would represent a link between the innate and acquired immune response ([@bib9]).

One of the main features occurring during M*Φ* activation involves arginine metabolism and the synthesis of key molecules such as NO on one side and arginase, which may lead to the formation of polyamines, on the other. NO is a highly reactive molecule produced from a guanidine-nitrogen of arginine in a reaction catalyzed by NOS. NO is synthesized at high levels by M*Φ* upon stimulation by Th1 cytokines ([@bib12]; [@bib25]) and has been implicated in host defense ([@bib10]; [@bib11]; [@bib13]; [@bib18]; [@bib19]; [@bib37]). Arginase, an enzyme induced in M*Φ* upon stimulation by Th2 cytokines ([@bib12]; [@bib25]), drives the synthesis of ornithine, which is catalyzed by ODC to form polyamines (putrescine, spermidine and spermine). DFMO, an analog of ornithine, can irreversibly inhibit ODC causing polyamine depletion. Arginase has been implicated in virus inhibition and may potentially have an antimicrobial activity OR play an antimicrobial role ([@bib5]; [@bib21]). Polyamines, such as spermine, play several roles in cell differentiation and proliferation and may contribute to virus maturation ([@bib3]; [@bib36]; [@bib39]). Although data have shown that polyamine depletion reduces cytomegalovirus or herpes simplex virus 2 infectivity, contradictory reports are found in the literature ([@bib3]).

Our data show that after activation with IL-12/IL-18 or IFN*γ*, BALB/c and A/J BMM*Φ* released NO ([Fig. 4A](#fig4){ref-type="fig"}). Arginase was induced only when IL-4/IL-10 was used for activation ([Fig. 4B](#fig4){ref-type="fig"}). Higher arginine consumption was observed in BMM*Φ* from both strains upon IFN*γ* or IL-4 activation and, as expected, IFN*γ* activation led to higher citrulline synthesis and IL-4 activation to higher ornithine synthesis ([Fig. 1](#fig1){ref-type="fig"}, [Fig. 5](#fig5){ref-type="fig"}). Both arginine consumption and spermine synthesis increased during MHV3 infection. Although IL-12/IL-18 activation of both BALB/c and A/J BMM*Φ* led to NO synthesis ([Fig. 4A](#fig4){ref-type="fig"}), a higher consumption of arginine was not observed in this situation ([Fig. 5A](#fig5){ref-type="fig"}). IL-12/IL-18 or IFN*γ* activation, mainly in MHV3 infected cells, led to a decreased synthesis of spermine only in A/J BMM*Φ* ([Fig. 5D](#fig5){ref-type="fig"}). The putrescine and spermidine pattern levels followed that of spermine but at lower levels (data not shown). Intracellular polyamines were shown to be important during MHV3 replication since, in DFMO-treated BMM*Φ*, we detected a significant decrease in MHV3 titer ([Table 1](#tbl1){ref-type="table"}).

Our data of arginine metabolism in M*Φ* ([Fig. 5](#fig5){ref-type="fig"}) are consistent with the notion that the newly established autocrine M*Φ* activation leads to IFN*γ* synthesis which in turn induces NO synthesis ([Fig. 2](#fig2){ref-type="fig"}, [Fig. 4](#fig4){ref-type="fig"}). The lack of arginase induction indicates the Th1 behavior of this type of autocrine activation. The fact that upon exposure to IL-12/IL-18, which induces endogenous IFN*γ* ([Fig. 2](#fig2){ref-type="fig"}) and NO ([Fig. 4](#fig4){ref-type="fig"}), we failed to observe the expected arginine consumption and citrulline synthesis, clearly observed when exogenous IFN*γ* was employed ([Figs. 5A and B](#fig5){ref-type="fig"}), may rely on inherent quantitative and kinetic characteristics of the process.

Regarding the mechanism involved in resistance/susceptibility of mice to MHV3 infection, our previous ([@bib28]; [@bib38]) and present data obtained with BALB/c and A/J M*Φ*, clearly link IFN*γ* synthesis, anti-MHV3 state induction and polyamine inhibition in A/J M*Φ* ([Fig. 6A](#fig6){ref-type="fig"} ). In these M*Φ*, polyamines were induced during MHV3 infection and significantly inhibited upon activation by IFN*γ* or IL-12/IL-18. Supported by the data showing a decreased MHV3 replication in DFMO treated M*Φ* ([Table 1](#tbl1){ref-type="table"}), the polyamine modulation by IFN*γ* correlates with the anti-MHV3 state observed only among A/J M*Φ*. Nevertheless, the molecular basis of a mechanism underlying the influence of IFN*γ* on polyamine synthesis remains unclear.Fig. 6Schema of proposed mechanisms for resistant A/J (A) and susceptible BALB/c (B) mouse macrophages, involving autocrine and paracrine activation by IFN*γ* and MHV3 restriction of replication. M*Φ*, macrophage; Th1, T helper lymphocyte type 1; NK, natural killer cell; a, autocrine pathway; b, paracrine pathway; 1a, IL-12 and IL-18 synthesis by M*Φ*; 2a, IL-12 and IL-18 activation of M*Φ*; 3a, IFN*γ* synthesis by activated M*Φ*; 4a, IFN*γ* activation of M*Φ*; 5a, intracellular response to autocrine IFN*γ* activation leading to biliary glycoprotein (Bgp1^a^) virus receptor down-regulation and inhibition of polyamine synthesis; 1b, MHV3 activation of cellular immune response; 2b, synthesis of IFN*γ* by Th1 and NK cells; 3b, IFN*γ* activation of M*Φ*; 4b, intracellular response to paracrine IFN*γ* activation leading to Bgp1^a^ down-regulation and inhibition of polyamine synthesis; ↓ Bgp1^a^, down-regulation of Bgp1^a^; ■, Bgp1^a^ receptors on the cell membrane; ↓ polyamines, inhibition of polyamine synthesis.

Our findings show that both autocrine and paracrine processes of M*Φ* activation may participate in the inhibition of MHV3 replication and that the involvement of arginine metabolism in resistance to MHV3 may rely on the decreased synthesis of polyamines induced by IFN*γ* ([Fig. 5](#fig5){ref-type="fig"}, [Fig. 6](#fig6){ref-type="fig"})We can speculate that polyamines, besides their effects on cell differentiation, may participate directly in MHV3 maturation.

Altogether these data show the relevance of IFN*γ*, from autocrine or paracrine pathways, and suggest how arginine metabolism may be involved in the modulation of MHV3 replication in M*Φ* of a resistant mouse strain.
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[^1]: Supernatants were collected and virus titers evaluated. Data from independent experiments are reported as PFU/ml±SD. \*Significant ($p < 0.01$), as compared to controls.
